Pivot Blue works with pharma CMOs to connect fragmented data, activate AI where compliance allows, and prove the commercial value of marketing, without adding complexity or replacing what already exists.
These aren’t generic marketing challenges. They are the specific frustrations of senior pharma marketing leaders trying to drive growth in one of the most complex commercial environments in the world.
HCP, patient, CRM, media and sales force data all in separate systems. Decisions made in the dark. Marketing unable to connect activity to outcomes or defend spend with any real confidence.
The stack looks impressive on paper. But adoption is low, agencies have become the gatekeepers, and the technology that was supposed to transform marketing is delivering reports, not growth.
MLR approval cycles, GDPR in healthcare and risk-averse cultures create paralysis. The organisation talks about AI transformation while the team is still manually building campaign reports. There is a path forward, it just requires knowing where AI can move.
Indirect sales models, long HCP decision cycles and restricted data environments make attribution hard. But the CFO is asking, the board is asking, and “reach and frequency” is no longer an acceptable answer.
Pivot Blue works as your growth and transformation partner, connecting the strategy, data, technology, and AI that already exists in your organisation into one operating model that is accountable to commercial outcomes.
We understand pharma’s unique constraints — MLR processes, indirect sales models, HCP engagement rules, and global market complexity. We work within them, not around them.
Connect marketing activity to HCP prescribing behaviour and commercial outcomes, giving your CFO the attribution story they’ve been asking for.
Unify HCP, patient, CRM, media and sales force data into one intelligence layer, so every decision is grounded in a complete commercial picture.
Build HCP and patient journeys around real engagement patterns, not channel silos or internal org charts, to drive meaningful omnichannel impact.
Build HCP and patient journeys around real engagement patterns, not channel silos or internal org charts, to drive meaningful omnichannel impact.
Unlock the value already sitting inside Veeva, Salesforce Health Cloud and your media stack, without buying more technology or losing more control to agencies.
Embed AI where it can move within pharma’s compliance environment, next best action, channel optimisation, content personalisation, without triggering MLR paralysis.
Every engagement is outcome-led and designed around your specific situation, not a fixed programme sold to every client.
A rapid 4–6 week assessment that identifies exactly where your marketing operation is losing commercial value, across data, technology, channels and measurement.
Unify HCP, patient and commercial data into one actionable intelligence layer that connects marketing to prescribing behaviour and revenue outcomes.
Identify and activate the AI use cases that can move within your compliance environment, driving measurable performance without triggering MLR paralysis.
Senior marketing leaders trust Pivot Blue for practical perspectives on data, AI and commercial growth. No noise. No fluff.
Tell us where your pharma marketing operation is today. We’ll be direct about where we can help and how fast we can move.
Book a free 30-minute call →